Evidence-based effective and safe interventions in ASD are highly sought after in order to ease some of the behavioral problems seen in this condition
Treatment with semaglutide reduces risk of death or morbidity from cardiovascular disease- in the SUSTAIN 6 trial (104 weeks, 3297 patients with diabetes and high cardiovascular risk), the risk of developing cardiovascular death, myocardial infarction (heart attack) or stroke was reduced by 26% in the patients treated with semaglutide (Ozempic)
Its involved in hundreds of enzyme-driven reactions that help your cells produce energy, regulate iron metabolism, build healthy connective tissue, support normal skin and hair pigmentation, protect against oxidative stress, and maintain healthy brain and nervous system function
Your lab values reveal your true metabolic status, showing improvements in: Insulin sensitivity Inflammatory markers Cardiovascular risk factors Liver health These changes often precede significant weight loss, confirming the medication is working even before dramatic scale changes